Patient was educated on Pradaxa and its mechanism of action as follows:

  1. Pradaxa is an anticoagulant inhibiting some proteins that help clotting.
  2. Pradaxa inhibits the thrombin factor along the coagulation pathway.
  3. Pradaxa helps individuals with atrial fibrillation, by preventing formation of clot and consequent stroke.
  4. Inhibition of clot formation also offers protection against deep venous thrombosis, consequent development of pulmonary embolism and episodes of myocardial infarction and chest pain.
  5. So, Pradaxa is widely used in individuals undergoing hip and knee surgeries and other procedures that involve prolonged immobilization and a high risk for prolonged development of deep venous thrombosis.